CLINICAL OUTCOMES OF PATIENTS ON COMBINATION THERAPY IN INFLAMMATORY BOWEL DISEASE PATIENTS

被引：0
|
作者：
Thurston, Theresa
Moskow, Joshua
Abraham, Bincy P.
Glassner, Kerri
机构：
来源：
GASTROENTEROLOGY | 2023年 / 164卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Tu1797
引用
收藏
页码：S1132 / S1133
页数：2
相关论文
共 50 条
  • [1] Clinical outcomes amongst elderly patients with inflammatory bowel disease
    Sivanathan, Vithoosharan
    Basnayake, Chamara
    Connell, William
    Wright, Emily
    Ding, John Nik
    Niewadomski, Ola
    Stanley, Annalise
    Wilson-O'Brien, Amy
    Fry, Stephanie
    Samyue, Tamie
    Lust, Mark
    Flanagan, Emma
    Thompson, Alexander J., V
    Kamm, Michael A.
    INTERNAL MEDICINE JOURNAL, 2023, 53 (10) : 1866 - 1874
  • [2] Which patients with inflammatory bowel disease should receive combination therapy?
    Cross, Raymond K.
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2015, 9 (06) : 715 - 717
  • [3] Is advanced combination therapy effective in patients with refractory Inflammatory Bowel Disease?
    Gallardo, M. Rodriguez
    Delgado, T. Valdes
    Perez, B. Maldonado
    Jimenez, M. Belvis
    Paredes, A. Aguado
    Laria, L. Castro
    Arias, F. Arguelles
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1195 - i1196
  • [4] PREDICTIVE MODEL FOR CLINICAL OUTCOMES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE RECEIVING MAINTENANCE THERAPY WITH INFLIXIMAB
    Wong, Rochelle
    Charilaou, Paris
    Hemperly, Amy
    Qin, Lihui
    Pan, Yushan
    Mahtani, Prerna
    Longman, Randy S.
    Boland, Brigid S.
    Dulai, Parambir S.
    Holmer, Ariela
    Lukin, Dana J.
    Singh, Siddharth
    Valasek, Mark A.
    Sandborn, William J.
    Scherl, Ellen J.
    Casteele, Niels Vande
    Battat, Robert J.
    GASTROENTEROLOGY, 2023, 164 (06) : S1116 - S1116
  • [5] Genetic Markers Associated with Clinical Outcomes in Patients with Inflammatory Bowel Disease
    Yamamoto-Furusho, Jesus K.
    Fonseca-Camarillo, Gabriela
    INFLAMMATORY BOWEL DISEASES, 2015, 21 (11) : 2683 - 2695
  • [6] Clinical Features and Outcomes in Patients with Inflammatory Bowel Disease and Concomitant Sarcoidosis
    Shahi, Varun
    Khanna, Sahil
    Loftus, Edward
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 : S557 - S557
  • [7] The Impact of Thiopurine Hypermethylation on Clinical Outcomes in Patients With Inflammatory Bowel Disease
    Blaker, Paul A.
    Fong, Steven C.
    Smith, Melissa A.
    Kariyawasam, Viraj C.
    Marinaki, Anthony M.
    Irving, Peter M.
    Sanderson, Jeremy D.
    GASTROENTEROLOGY, 2014, 146 (05) : S246 - S246
  • [8] De-escalation of Combination Drug Therapy in Inflammatory Bowel Disease Patients
    Saleh, Adam A.
    Waghela, Rajdeepsingh
    Garza, Manuel
    Stading, Rachel
    Miroballi, Natalia
    Moskow, Joshua
    Thurston, Theresa
    Abraham, Bincy
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S722 - S722
  • [9] Ustekinumab and Anti-TNF Combination Therapy in Patients with Inflammatory Bowel Disease
    Yzet, Clara
    Dupas, Jean-Louis
    Fumery, Mathurin
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 (05): : 748 - 749
  • [10] Duration of combination therapy and risk of treatment failure in patients with inflammatory bowel disease
    Lambrescak, Elsa
    Vaysse, Thibaut
    Allez, Matthieu
    Ungar, Bella
    Gleizes, Aude
    Hacein-Bey, Salima
    Chowers, Yehuda
    Roblin, Xavier
    Kopylov, Uri
    Rachas, Antoine
    Carbonnel, Franck
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2021, 45 (02)
12345